Table 5.
State of the art antibody production methods and their dependence on Cabilly II and III
| Production method | Company | Patent | Protected by Cabilly II? | Protected by Cabilly III? | ||
| Heterologous Dimeric Protein Production in Heterokaryons | Neugenesis | ![]() |
US5643745 | No, because two cell lines are independently transformed with HC DNA and LC DNA, and are then fused | Probably yes | |
| Milk secretion in transgenic mammals | GTC Biotherapeutics | ![]() |
US5827690 | No, because transgenic animal comprises a full repertoire of heavy and LC genes, i.e. no transformation of a host cell, and expression takes place in hybridoma cells | No, because no recombinant host cells (cells which have been transformed with vectors used) | |
| Hybridoma cells obtained from transgenic rodents or mice | Regeneron VelocImmune | ![]() |
US7105348 | |||
| Expression of monoclonal antibodies in ciliate host cells with different mating types | Cilian AG | ![]() |
WO2011107520 | No, because two cells which have been trasformed with HC and Lc, respectively, can be conjugated to express full antibody | Probably yes |



